Zacks Small Cap Research on MSN5h
ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements
ORMP READ THE FULL ORMP RESEARCH REPORT Planning Phase 3 Oral Insulin study under revised protocol, new CRO agreement in ...
New diabetes treatment delays onset of Type 1 diabetes; UH treats first NE Ohio patient
Parma woman was among the first patients in Northeast Ohio to receive the first FDA-approved drug, Tzield that can delay the ...
2minutemedicine.com12h
Novo Nordisk’s Rybelsus demonstrates reduction in cardiovascular events for patients with Type 2 diabetes and cardiovascular disease
Rybelsus in combination with standard T2DM therapy reduced the risk of major cardiovascular events by 14% in patients with ...
News Medical on MSN12d
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options
Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...